Prismaflex®
一个用于以下疗法的集成系统:
CRRT (持续性肾脏替代疗法)
HP (血液灌流)
TPE (治疗性血浆置换)
操作手册
适用于软件版本 4.XX 服务代码 G5038101
一个用于以下疗法的集成系统:
CRRT (持续性肾脏替代疗法)
HP (血液灌流)
TPE (治疗性血浆置换)
适用于软件版本 4.XX 服务代码 G5038101
Gambro Lundia AB, Box 10101, SE-220 10 Lund, Sweden ;电话: +46-46-16 90 00 ;传真: +46-46-16 96 96 ; www.gambro.com
如对本手册有任何意见或建议,请联系当地销售代表或制造商。
© 2005–2009 Gambro Lundia AB
Prismaflex® 是以 Gambro Lundia AB 和 Gambro Industries SAS 的名义在澳大利亚、中国、法国、中国香港、俄罗斯 联邦、美国、日本、共同体商标(欧盟)和韩国注册的商标。
Adsorba® 是以 Gambro Lundia AB 、 Gambro Hospal (Schweiz) AG 和 Gambro AG 的名义在奥地利、比荷卢、加拿 大、德国、阿尔及利亚、埃及、共同体商标(欧盟)、西班牙、法国、英国、匈牙利、意大利、日本、列支敦士登、摩 洛哥、摩纳哥、葡萄牙、罗马尼亚、俄罗斯联邦、瑞典、圣马力诺、美国、越南以及塞尔维亚和黑山共和国注册的商 标。
Prismaflo® 是以 Gambro Lundia AB 、 Gambro Industries SAS 和 Hospal International Marketing Management 的名 义在阿尔巴尼亚、奥地利、波黑、保加利亚、瑞士、中国、阿尔及利亚、埃及、共同体商标 (欧盟)、法国、中国香 港、克罗地亚、冰岛、摩洛哥、摩尔多瓦、前南斯拉夫马其顿共和国、墨西哥、挪威、新加坡、土耳其、中国台湾、乌 克兰、美国、加拿大和韩国注册的商标。
Prismacomfort™是以Gambro Lundia AB的名义在挪威、共同体商标(EU)和瑞士注册的商标,并已在美国提出申请。
Prismatherm® 是以 Gambro Lundia AB 的名义在美国注册的商标。
Gambro® 是 Gambro Lundia AB 的注册商标。
Hospal® 是 Gambro Hospal Switzerland Ltd. 的注册商标。
Prismaflex® 机器受下列一项或多项专利 / 设计的保护:
D540948 (设计)
西班牙: 0532432, 0678301, 0611228, 0829265, 0925826, 1320394, 0643301, 0305787, 0441721, 0701830, 0706044
欧盟(设计): 15870
加拿大: 2077848, 2303714, 2115414, 2444794, 2158245
法国: 9111351, 9716732, 9411216, 9412252
意大利: 01320264
日本: 3369223, 3413412, 3591864, 2823513, 3047403, 3254222, 3690846
| 目录 |
|---|
| Prismaflex®.................................................................................................................................1 |
| 目录...............................................................3 |
| 图................................................................11 |
| 表................................................................13 |
| 第1章:用前须知.................................................15 |
| 1.1 用途......................................................................15 |
| 1.2 禁忌症....................................................................15 |
| 1.3 治疗概述..................................................................15 |
| 1.3.1 Prismaflex疗法选项....................................................15 |
| 1.3.2 治疗机理.............................................................16 |
| CRRT机理......................................................16 |
| CRRT Septex机理................................................17 |
| TPE机理........................................................17 |
| HP机理.........................................................17 |
| 1.3.3 Prismaflex疗法说明....................................................17 |
| HP(血液灌流)..................................................24 |
| 1.3.4 Prismaflex抗凝血选项..................................................25 |
| 抗凝血方式和疗法................................................25 |
| 1.4 查找有关Prismaflex系统的信息.............................................26 |
| 1.4.1 操作手册.............................................................26 |
| 1.4.2 联机说明.............................................................26 |
| 1.4.3 Prismaflex配套的使用说明..............................................26 |
| 1.5 责任和免责声明............................................................26 |
| 1.6 使用前的一般警告和注意事项................................................27 |
| 1.6.1 警告.................................................................27 |
| 1.6.2 注意.................................................................32 |
G5038101:4.XX
3
Prismaflex® 操作手册
| 1.7 安全定义**.............................................................................................................**34 |
|---|
| 1.8 符号**...................................................................................................................**35 |
| 1.9 认证标**志.............................................................................................................**38 |
| 1.10 安装**....................................................................................................................**39 |
| 1.11 服务**信息.............................................................................................................**39 |
| 1.12 运输**....................................................................................................................**39 |
| 1.13 处**置....................................................................................................................**39 |
| 1.13.1 电池处置.............................................................39 |
| 1.13.2 包装材料处置.........................................................39 |
| 1.13.3 废弃设备处置.........................................................39 |
| 1.13.4 ............................................................................................. 40 |
| 第2章:本机器及其部件的说明.....................................41 |
| 2.1 **前言...................................................................................................................**41 |
| 2.1.1 血液输入.............................................................41 |
| 2.1.2 Prismaflex控制单元功能................................................41 |
| 2.2 系统**部件.............................................................................................................**42 |
| 2.2.1 控制单元.............................................................42 |
| 2.2.2 Prismaflex配套........................................................42 |
| 最低病人体重....................................................43 |
| CRRT配套部件..................................................44 |
| TPE配套部件....................................................46 |
| HP套件部件.....................................................48 |
| 2.2.3 液袋.................................................................50 |
| 2.3 Prismaflex**附件...................................................................................................**50 |
| 2.3.1 血液加温器...........................................................50 |
| 2.3.2 HP吸附器支架........................................................50 |
| 2.3.3 Prismaflex的UPS安装要求............................................50 |
| 2.4 Prismaflex控制单**元.............................................................................................**50 |
| 2.4.1 前面板...............................................................50 |
| 2.4.2 后面板...............................................................56 |
| 2.4.3 内部部件.............................................................57 |
| 2.5 Prismaflex系统自检**............................................................................................**57 |
| 2.5.1 初始化测试...........................................................57 |
| 2.5.2 预充自检.............................................................57 |
| 2.5.3 定期自检.............................................................58 |
| 定期自检期间的报警监控..........................................58 |
| 将定期自检信号静音..............................................58 |
G5038101: 4.XX
4
目录
| 第3章 | :一般治疗信息.............................................59 |
|---|---|
| 3.1 系统 |
概述..................................................................59 |
| 3.1.1 | 与Prismaflex控制单元通信.............................................59 |
| 交互显示........................................................59 | |
| 使用者可控制的设定..............................................59 | |
| 3.1.2 | 泵...................................................................60 |
| 3.1.3 | 流速设定.............................................................61 |
| 调整流速设定....................................................61 | |
| 治疗期间查看流速设定............................................61 | |
| PBP流速和血泵流速..............................................62 | |
| 置换溶液输注选项(CRRT)..................................................................................62 |
|
| 前稀释总值......................................................63 | |
| 3.1.4 | 使用“标准”抗凝血方式进行抗凝剂设定................................64 |
| 调整抗凝剂设定..................................................64 | |
| 治疗期间查看抗凝剂设定..........................................64 | |
| 3.1.5 | 在抗凝剂设定中选择柠檬酸盐抗凝血方式.................................65 |
| 需要考虑的因素..................................................65 | |
| 柠檬酸盐处方....................................................66 | |
| 血液流速........................................................66 | |
| 病人柠檬酸盐估计负载量..........................................66 | |
| 柠檬酸盐剂量范围................................................67 |
|
| 血流范围........................................................67 | |
| 调整柠檬酸盐抗凝剂设定..........................................68 | |
| 治疗期间查看抗凝剂设定..........................................68 | |
| 3.1.6 | 病人脱水流速(CRRT)...................................................................................................68 |
| 计算所需的病人脱水流速..........................................68 | |
| 调整病人脱水流速................................................69 | |
| 病人脱水流速机器控制............................................69 | |
| 设置“病人液体损失或增加量限制” ...............................69 | |
| 3.1.7 | 液体平衡.............................................................70 |
| 病人脱水量......................................................70 | |
| 3.1.8 | 检查处方设定.........................................................70 |
| CRRT处方指标..................................................71 | |
| 柠檬酸盐抗凝血指标..............................................71 | |
| 3.1.9 | 历史数据.............................................................72 |
| I/O数据.........................................................72 | |
| 事件............................................................73 | |
| 图表............................................................74 | |
| 治疗后的历史数据................................................75 | |
| 掉电期间的历史数据..............................................75 | |
| 保存历史数据....................................................75 | |
| 3.1.10 | 报警安全系统.........................................................76 |
G5038101:4.XX
5
Prismaflex® 操作手册
| 3.1.11 | 监控系统.............................................................76 |
|---|---|
| 压力............................................................76 | |
| 血液漏出........................................................76 | |
| 气泡............................................................76 | |
| 病人连接........................................................76 | |
| 3.2 操作 |
......................................................................77 |
| 3.2.1 | 启动.................................................................77 |
| 3.2.2 | 控制和导航...........................................................78 |
| 3.2.3 | 画面布局.............................................................78 |
| 3.2.4 | 工作模式.............................................................79 |
| 建立模式........................................................79 | |
| 待命模式........................................................83 | |
| 运行模式........................................................84 | |
| 结束模式........................................................86 | |
| 结束模式下的再循环..............................................89 | |
| 3.2.5 | 自定义模式...........................................................91 |
| 3.2.6 | 使用者可控制的设定...................................................93 |
| 3.2.7 | 注射器安装程序......................................................100 |
| 注射器控制面板.................................................100 | |
| 注射器初始安装.................................................101 | |
| 在治疗或循环期间更换注射器.....................................101 | |
| 3.2.8 | 更换液袋功能........................................................101 |
| Prismaflex控制单元操作..........................................101 | |
| 治疗期间在可变空液袋模式下更改允许的袋容量.....................101 | |
| 治疗期间更换液袋...............................................102 | |
| 3.3 压力 |
监控.................................................................102 |
| 3.3.1 | 输入、过滤器及废液监控部件..........................................103 |
| 3.3.2 | 回输压力监控部件....................................................103 |
| 3.3.3 | 工作期间的压力......................................................104 |
| 3.3.4 | 输入压力监控范围....................................................104 |
| 3.3.5 | 极端压力限制........................................................105 |
| 3.3.6 | 压力工作点..........................................................106 |
| 初始值.........................................................106 | |
| 随后的值.......................................................107 | |
| 压力趋向限制...................................................107 | |
| “不能检测到断开”限制..........................................108 | |
| 3.3.7 | 软件计算的压力......................................................108 |
| 跨膜压(TMP)......................................................................................................108 | |
| 过滤器压力下降(压力下降)....................................109 |
G5038101:4.XX
6
目录
| 第4章 | :治疗性血浆置换(TPE).................................................................111 |
|---|---|
| 4.1 系统 |
概述.................................................................111 |
| 使用者可控制的设定.............................................111 | |
| 4.1.1 | TPE处方和流速......................................................111 |
| 调整TPE处方和流速............................................112 | |
| 治疗期间查看TPE处方和流速设定................................112 | |
| 使用PBP溶液的注意事项........................................112 | |
| 病人血浆丢失速率...............................................112 | |
| TPE中使用的公式...............................................113 | |
| 4.1.2 | 血浆平衡............................................................114 |
| 病人血浆丢失量.................................................114 | |
| 4.1.3 | 历史数据............................................................115 |
| 治疗数据.......................................................115 | |
| 图表...........................................................116 | |
| 4.2 操作 |
.....................................................................116 |
| 4.2.1 | 工作模式............................................................116 |
| 建立模式.......................................................116 | |
| 待命模式.......................................................121 | |
| 运行模式.......................................................122 | |
| 4.3 压力 |
监控.................................................................125 |
| 4.3.1 | 工作期间的压力......................................................125 |
| 4.3.2 | 输入压力监控范围....................................................125 |
| 4.3.3 | 极端压力限制........................................................126 |
| 4.3.4 | 软件计算的压力......................................................127 |
| 输入跨膜压(TMPa)............................................................................................127 | |
| 过滤器压力下降(压力下降)....................................128 | |
| 第5章 | :血液灌流(HP)..............................................................................131 |
| 5.1 系统 |
概述.................................................................131 |
| 使用者可控制的设定.............................................131 | |
| 5.1.1 | 流速和抗凝剂设定....................................................131 |
| 调整流速和抗凝剂设定...........................................131 | |
| 治疗期间查看流速设定...........................................131 | |
| 使用PBP溶液的注意事项........................................132 | |
| 5.1.2 | 历史数据............................................................132 图表...........................................................132 |
G5038101:4.XX
7
Prismaflex® 操作手册
| 5.2 操作.....................................................................132 |
|---|
| 5.2.1 工作模式............................................................132 |
| 建立模式.......................................................132 |
| 待命模式.......................................................136 |
| 运行模式.......................................................137 |
| 5.3 压力监控.................................................................138 |
| 5.3.1 工作期间的压力......................................................139 |
| 5.3.2 输入压力监控范围....................................................139 |
| 5.3.3 极端压力限制........................................................139 |
| 5.3.4 软件计算的压力......................................................140 |
| 第6章:报警系统................................................143 |
| 6.1 警告性报警...............................................................143 |
| 6.1.1 控制单元操作........................................................143 |
| 6.1.2 操作员响应..........................................................144 |
| 6.1.3 被忽略的警告性报警..................................................144 |
| 6.2 故障报警.................................................................144 |
| 6.2.1 控制单元操作........................................................144 |
| 6.2.2 操作员响应..........................................................145 |
| 6.2.3 被忽略的故障报警....................................................145 |
| 6.3 警示性报警...............................................................146 |
| 6.3.1 控制单元操作........................................................146 |
| 6.3.2 操作员响应..........................................................146 |
| 6.4 建议性报警...............................................................147 |
| 6.4.1 控制单元操作........................................................147 |
| 6.4.2 操作员响应..........................................................147 |
| 6.4.3 被忽略的建议性报警..................................................147 |
| 6.5 报警优先级别.............................................................148 |
| 第7章:难点释疑................................................149 |
| 7.1 警告性报警难点释疑.......................................................150 |
| 7.2 故障性报警难点释疑.......................................................165 |
| 7.3 警示性报警难点释疑.......................................................182 |
| 7.4 建议性报警难点释疑.......................................................194 |
| 7.5 其他难点释疑.............................................................205 |
G5038101:4.XX
8
| 目录 7.6 手动终止治疗.............................................................207 |
|---|
| 7.6.1 手动终止时进行回血..................................................207 |
| 7.6.2 手动终止而不进行回血................................................209 |
| 7.7 压力接头调整程序.........................................................209 |
| 7.7.1 压力接头调整(CRRT、HP)........................................209 |
| 所需用品.......................................................209 |
| 输入压力接头及废液压力接头.....................................210 |
| 过滤器压力接头.................................................211 |
| 7.7.2 压力接头调整(TPE).....................................................................................................212 |
| 所需用品.......................................................212 |
| 输入压力接头(TPE)...........................................................................................212 |
| 过滤器及废液压力接头(TPE)...........................................................................213 |
| 7.8 空气排出程序.............................................................214 |
| 7.8.1 排气室..............................................................214 |
| 7.8.2 “血液中有气泡”报警— 手动排除空气................................215 |
| 7.9 漏血探测器重调...........................................................215 |
| 第8章:保养....................................................217 |
| 8.1 维修.....................................................................217 |
| 8.2 操作员维护...............................................................217 |
| 8.2.1 例行清洁............................................................217 |
| 8.2.2 清洁漏血探测器......................................................217 |
| 8.2.3 清洁触屏............................................................217 |
| 8.3 预防性技术检修...........................................................218 |
| 8.3.1 定期安全检查........................................................219 |
| 第9章:规格....................................................221 |
| 附录A:指引及制造商声明— 电磁发射与抗扰度....................233 |
| 附录B:病人脱水量:历史数据中的异常............................237 |
| B.1 根本原因.................................................................237 |
| B.2 PFR异常的识别...........................................................237 |
| B.3 继续治疗.................................................................238 |
| 附录C:液体平衡说明(CRRT)..................................................................239 |
| C.1 流速................................................................................................................ 239 |
G5038101:4.XX
9
| Prismaflex® 操作手 C.2 |
册 Prismaflex 的流速监控方法............................................................................. 239 |
|---|---|
| PBP溶液、透析液、置换液和废液............................................................. 239 | |
| C.3 | Prismaflex确定病人实际脱水量的方法............................................................. 239 |
| C.4 | 防止病人液体失衡............................................................................................ 240 |
| C.5 | “错误的重量变化”报警................................................................................... 240 |
| 病人意外脱水量或增加量............................................................................ 241 | |
| 触发“错误的重量变化”报警的常见原因................................................ 241 | |
| 矫正“错误的重量变化”报警................................................................... 241 | |
| C.6 | “病人液体损失或增加量限制”.......................................................................... 242 |
| C.7 | “达到损失量/增加量限制”报警...................................................................... 242 |
| C.8 | 警告................................................................................................................ 242 |
| C.9 | 注意事项.......................................................................................................... 243 |
| 附录 | D:血浆平衡说明(TPE).....................................................................245 |
| D.1 | 流速.....................................................................245 |
| D.2 | Prismaflex 的流速监控方法.................................................245 |
| PBP溶液、置换液和废液.........................................245 | |
| D.3 | Prismaflex确定病人实际血浆丢失量的方法....................................245 |
| 使用PBP溶液的注意事项........................................246 | |
| D.4 | 防止病人血浆失衡.........................................................246 |
| D.5 | “错误的重量变化”报警...................................................247 |
| 触发“错误的重量变化”报警的常见原因..........................247 | |
| 矫正“错误的重量变化”报警....................................247 | |
| D.6 | “‘错误的重量变化’报警未清除”报警......................................248 |
| D.7 | 警告.....................................................................248 |
| D.8 | 注意事项.................................................................249 |
| 附录 | E:血液加温 251 |
| 器................................................................................... | |
| E.1 | 加温................................................................................................................ 251 |
| E.2 | Prismaflo血液加温器...................................................................................... 251 |
| E.3 | Prismatherm II血液加温器............................................................................. 251 |
| E.4 | Prismacomfort血液加温器.............................................................................. 252 |
G5038101:4.XX
10
预览结束 · 共 268 页
下载完整版